ArticleCancer discovery2025

AMG 193, a Clinical Stage MTA-Cooperative PRMT5 Inhibitor, Drives Antitumor Activity Preclinically and in Patients with MTAP-Deleted Cancers.

Brian Belmontes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.